• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

ApiJect picks up $111M investment from Royalty Pharma, Jefferies

May 18, 2022 By Sean Whooley

ApijectInjection delivery system developer ApiJect announced today that it completed a private investment round worth $111 million.

Royalty Pharma and Jefferies Financial Group led the investment round. Jefferies also acquired a revenue interest in addition to equity through the financing.

According to a news release, the investment round values ApiJect at approximately $300 million. Jefferies and ApiJect’s other lenders also converted all of their debt into ApiJect equity, leaving ApiJect with no debt on its balance sheet following this transaction.

The company said the funds raised will be used for the development of its proprietary Blow-Fill-Seal (BFS) plastic pre-filled injection system, as well as to deploy its equipment and proprietary technologies to licensees and for general working capital purposes.

BFS manufacturing, recognized by the FDA as an advanced aseptic process for forming, filling and sealing a single unit dose in a continuous, automated manufacturing step, greatly reduces the risk of contamination and error in drug production. ApiJect said developments for temperature management now allow BFS manufacturing for a wide range of sterile injectable drugs, including ultra-cold mRNA vaccines.

“This is an important day for injection device innovation, and, with that, the future health of billions of people throughout the world,” ApiJect CEO Jay Walker said in the release. “The investment provided by Royalty Pharma and Jefferies supports further development of an injection technology that can scale rapidly and efficiently to meet global demand for injectable medicines.”

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup, Pharmaceuticals Tagged With: ApiJect Systems

IN CASE YOU MISSED IT

  • Retractable Technologies declares dividends
  • Teva appoints former Vertex exec as new head of R&D, CMO
  • West Pharmaceutical Services debuts new needle syringe system
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS